DNA repair in cancer: emerging targets for personalized therapy

por Abbotts, Rachel, Thompson, Nicola, Madhusudan, Srinivasan
Publicado 2014

Pharmacologic Induction of BRCAness in BRCA-Proficient Cancers: Expanding PARP Inhibitor Use

por Abbotts, Rachel, Dellomo, Anna J., Rassool, Feyruz V.
Publicado 2022

PARP1 PARylates and stabilizes STAT5 in FLT3-ITD acute myeloid leukemia and other STAT5-activated cancers

por Dellomo, Anna J., Abbotts, Rachel, Eberly, Christian L., Karbowski, Mariusz, Baer, Maria R., Kingsbury, Tami J., Rassool, Feyruz V.
Publicado 2021

Metastasis Suppressor NME1 Modulates Choice of Double-Strand Break Repair Pathways in Melanoma Cells by Enhancing Alternative NHEJ while Inhibiting NHEJ and HR

por Puts, Gemma, Jarrett, Stuart, Leonard, Mary, Matsangos, Nicolette, Snyder, Devin, Wang, Ying, Vincent, Richard, Portney, Benjamin, Abbotts, Rachel, McLaughlin, Lena, Zalzman, Michal, Rassool, Feyruz, Kaetzel, David
Publicado 2020

Targeting human apurinic/apyrimidinic endonuclease 1 (APE1) in phosphatase and tensin homolog (PTEN) deficient melanoma cells for personalized therapy

por Abbotts, Rachel, Jewell, Rosalyn, Nsengimana, Jérémie, Maloney, David J, Simeonov, Anton, Seedhouse, Claire, Elliott, Faye, Laye, Jon, Walker, Christy, Jadhav, Ajit, Grabowska, Anna, Ball, Graham, Patel, Poulam M, Newton-Bishop, Julia, Wilson, David M, Madhusudan, Srinivasan
Publicado 2014